Cargando…

Reirradiation for local recurrence of oral, pharyngeal, and laryngeal cancers: a multi-institutional study

This study aimed to examine the efficacy and toxicity of reirradiation in patients with locally recurrent oral, pharyngeal, and laryngeal cancers. We conducted a retrospective, multi-institutional analysis of 129 patients with previously irradiated cancer. The most frequent primary sites were the na...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yamazaki, Hideya, Suzuki, Gen, Aibe, Norihiro, Shiomi, Hiroya, Oh, Ryoong-jin, Yoshida, Ken, Nakamura, Satoaki, Konishi, Koji, Ogita, Mikio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9944926/ https://www.ncbi.nlm.nih.gov/pubmed/36810749 http://dx.doi.org/10.1038/s41598-023-29459-2

Ejemplares similares

Reirradiation for Nasal Cavity or Paranasal Sinus Tumor—A Multi-Institutional Study
por: Yamazaki, Hideya, et al.
Publicado: (2021)

Reirradiation for Rare Head and Neck Cancers: Orbit, Auditory Organ, and Salivary Glands
por: Yamazaki, Hideya, et al.
Publicado: (2022)

A surveillance study of patterns of reirradiation practice using external beam radiotherapy in Japan
por: Yamazaki, Hideya, et al.
Publicado: (2020)

Reirradiation using robotic image-guided stereotactic radiotherapy of recurrent head and neck cancer
por: Yamazaki, Hideya, et al.
Publicado: (2016)

Radiotherapy for laryngeal cancer—technical aspects and alternate fractionation
por: Yamazaki, Hideya, et al.
Publicado: (2017)

Radiotherapy for locally advanced resectable T3–T4 laryngeal cancer—does laryngeal preservation strategy compromise survival?
por: Yamazaki, Hideya, et al.
Publicado: (2018)

Potential Risk of Other-Cause Mortality Due to Long-Term Androgen Deprivation Therapy in Elderly Patients with Clinically Localized Prostate Cancer Treated with Radiotherapy—A Confirmation Study
por: Yamazaki, Hideya, et al.
Publicado: (2020)

Radiotherapy for Clinically Localized T3b or T4 Very-High-Risk Prostate Cancer-Role of Dose Escalation Using High-Dose-Rate Brachytherapy Boost or High Dose Intensity Modulated Radiotherapy
por: Yamazaki, Hideya, et al.
Publicado: (2021)

Conventional dose versus dose escalated radiotherapy including high-dose-rate brachytherapy boost for patients with Gleason score 9–10 clinical localized prostate cancer
por: Yamazaki, Hideya, et al.
Publicado: (2022)

Reirradiation of head and neck cancer focusing on hypofractionated stereotactic body radiation therapy
por: Yamazaki, Hideya, et al.
Publicado: (2011)

Predictive value of skin invasion in recurrent head and neck cancer patients treated by hypofractionated stereotactic re-irradiation using a cyberknife
por: Yamazaki, Hideya, et al.
Publicado: (2015)

Effect of intratumoral abscess/necrosis on the outcome for head and neck cancer patients treated by hypofractionated stereotactic re-irradiation using CyberKnife®
por: Yamazaki, Hideya, et al.
Publicado: (2017)

Ultrahypofractionated Radiotherapy versus Conventional to Moderate Hypofractionated Radiotherapy for Clinically Localized Prostate Cancer
por: Yamazaki, Hideya, et al.
Publicado: (2021)

Clinical outcome of patients treated with re-irradiation for spine or pelvic bone metastasis: A multi-institutional analysis of 98 patients
por: Suzuki, Gen, et al.
Publicado: (2017)

Quantitative assessment of inter-observer variability in target volume delineation on stereotactic radiotherapy treatment for pituitary adenoma and meningioma near optic tract
por: Yamazaki, Hideya, et al.
Publicado: (2011)

Radiotherapy for elder patients aged ≥80 with clinically localized prostate cancer – Brachytherapy enhanced late GU toxicity especially in elderly
por: Yamazaki, Hideya, et al.
Publicado: (2020)

Novel Prognostic Index of High-Risk Prostate Cancer Using Simple Summation of Very High-Risk Factors
por: Yamazaki, Hideya, et al.
Publicado: (2021)

Comparison of radiation dermatitis between hypofractionated and conventionally fractionated postoperative radiotherapy: objective, longitudinal assessment of skin color
por: Yamazaki, Hideya, et al.
Publicado: (2018)

Measurement of exhaled nitric oxide and serum surfactant protein D levels for monitoring radiation pneumonitis following thoracic radiotherapy
por: Yamazaki, Hideya, et al.
Publicado: (2017)

Potential risk of alpha-glucosidase inhibitor administration in prostate cancer external radiotherapy by exceptional rectal gas production: a case report
por: Nishimura, Takuya, et al.
Publicado: (2014)

Radiotherapy for Elderly Patients Aged ≥75 Years with Clinically Localized Prostate Cancer—Is There a Role of Brachytherapy?
por: Yamazaki, Hideya, et al.
Publicado: (2018)

Comparison of toxicities between ultrahypofractionated radiotherapy versus brachytherapy with or without external beam radiotherapy for clinically localized prostate cancer
por: Yamazaki, Hideya, et al.
Publicado: (2022)

High-dose-rate brachytherapy with external beam radiotherapy versus low-dose-rate brachytherapy with or without external beam radiotherapy for clinically localized prostate cancer
por: Yamazaki, Hideya, et al.
Publicado: (2021)

Effect of Androgen Deprivation Therapy on Other-Cause of Mortality in Elderly Patients with Clinically Localized Prostate Cancer Treated with Modern Radiotherapy: Is There a Negative Impact?
por: Yamazaki, Hideya, et al.
Publicado: (2019)

Role of Brachytherapy Boost in Clinically Localized Intermediate and High-Risk Prostate Cancer: Lack of Benefit in Patients with Very High-Risk Factors T3b–4 and/or Gleason 9–10
por: Yamazaki, Hideya, et al.
Publicado: (2022)

A surveillance study of the current status of reirradiation and patterns of practice
por: Yamazaki, Hideya, et al.
Publicado: (2017)

Outcome and toxicity of stereotactic body radiotherapy with helical tomotherapy for inoperable lung tumor: analysis of Grade 5 radiation pneumonitis
por: Aibe, Norihiro, et al.
Publicado: (2014)

Evaluation of dosimetry and excess seeds in permanent brachytherapy using a modified hybrid method: a single-institution experience
por: Kobayashi, Kana, et al.
Publicado: (2013)

＜Editors’ Choice＞ Elective nodal irradiation versus involved field radiotherapy for limited disease small cell lung cancer: a single-institution experience
por: Suzuki, Gen, et al.
Publicado: (2022)

Laryngitis, epiglottitis and pharyngitis
por: Bourayou, Rafik, et al.
Publicado: (2010)

Laryngitis, Epiglottitis and Pharyngitis
por: Pham, Luu-Ly, et al.
Publicado: (2017)

Effective heart-sparing whole lung irradiation using volumetric modulated arc therapy: a case report
por: Suzuki, Gen, et al.
Publicado: (2019)

The Feasibility of Omitting Postoperative Radiotherapy in Japanese Patients With Ductal Carcinoma In Situ of Breast Treated With Breast-Conserving Surgery
por: Nakashima, Akihiro, et al.
Publicado: (2023)

Unexpected lower biochemical control of high-dose-rate brachytherapy boost than low-dose-rate brachytherapy boost for clinically localized prostate cancer
por: Yamazaki, Hideya, et al.
Publicado: (2020)

Comparison of Image-Guided Intensity-Modulated Radiotherapy and Low-dose Rate Brachytherapy with or without External Beam Radiotherapy in Patients with Localized Prostate Cancer
por: Tsubokura, Takuji, et al.
Publicado: (2018)

Author Correction: Comparison of Image-Guided Intensity-Modulated Radiotherapy and Low-dose Rate Brachytherapy with or without External Beam Radiotherapy in Patients with Localized Prostate Cancer
por: Tsubokura, Takuji, et al.
Publicado: (2018)

Endoscopic submucosal dissection followed by chemoradiotherapy for superficial esophageal cancer: choice of new approach
por: Suzuki, Gen, et al.
Publicado: (2018)

Stereotactic body radiotherapy for Stage I lung cancer with chronic obstructive pulmonary disease: special reference to survival and radiation-induced pneumonitis
por: Inoue, Toshihiko, et al.
Publicado: (2015)

High-Dose-Rate Brachytherapy Monotherapy versus Image-Guided Intensity-Modulated Radiotherapy with Helical Tomotherapy for Patients with Localized Prostate Cancer
por: Yamazaki, Hideya, et al.
Publicado: (2018)

Clinical Usefulness of the Platelet-to Lymphocyte Ratio in Patients with Angiosarcoma of the Face and Scalp
por: Suzuki, Gen, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_s6q1jrkv12f6nil2uobh1p4h6s